Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Options trading offers unique opportunities to boost investment returns. Discover how to leverage options for greater gains.
25,570 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
GOP-led statehouses are intensifying limits on abortion pills, while a new survey links telehealth-based pill use to ...
A Florida appeals court ruled that undisbursed funds from a reverse mortgage line of credit are protected by the home...
Biotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
Fan tokens are shifting from novelty to data assets, with clubs using on chain activity to measure sentiment, reward ...
New data highlights a tougher entry to the workforce for Gen Z graduates compared with Millennials, with a large shar...
Rigetti Computing stock rocketing headlines a broader burst of investor interest in quantum tech. Here’s what’s drivi...
A trio of ETFs focusing on nuclear and uranium stocks is catching investor attention as AI computing expands. The cas...
Cardano canceled its planned 2026 Summit in Singapore after a treasury voting process blocked funding, signaling the ...
A public rebuke of management sparks a wave of worker stories about the price of speaking up at work and how it affec...
As AI expands across mortgage processing and underwriting, lenders must adopt a responsible framework every mortgage ...
A wave of AI adoption is shifting from hype to daily practice, with firms treating AI as a strategic partner and buil...